Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
Journal of Medicinal Chemistry
|
February 17, 1998
5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents
J P Edwards, S J West, K B Marschke, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
December 5, 1998
Endovascular treatment of life-threatening peripheral pulmonary artery stenosis
A B Fontaine, D E Wood, J J Borsa, et al.
Journal of Medicinal Chemistry
|
February 2, 1999
Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071)
L G Hamann, N S Mani, R L Davis, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g] quinolinone
J P Edwards, S J West, C L Pooley, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 1, 2000
Effects of isosteric pyridone replacements in androgen receptor antagonists based on 1,2-dihydro- and 1,2,3,4-tetrahydro-2,2-dimethyl-6-trifluoromethyl-8-pyridono[5,6-g]quin olines
J W Kong, L G Hamann, D A Ruppar, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 1, 2000
Nonsteroidal progesterone receptor antagonists based on 6-thiophenehydroquinolines
L Zhi, C M Tegley, B Pio, et al.
Journal of Medicinal Chemistry
|
February 17, 1998
5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists
L Zhi, C M Tegley, E A Kallel, et al.
Journal of the American College of Cardiology
|
December 1, 1996
Acute results of balloon angioplasty of native coarctation versus recurrent aortic obstruction are equivalent. Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators
B W McCrindle, T K Jones, W R Morrow, et al.
Journal of Medicinal Chemistry
|
August 28, 1998
Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore
C L Pooley, J P Edwards, M E Goldman, et al.
Gynecologic Oncology
|
October 1, 1982
Carcinoma of the uterine cervix FIGO Stage I-B
L L Adcock, T M Julian, T Okagaki, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
Journal of Medicinal Chemistry
|
February 17, 1998
5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents
J P Edwards, S J West, K B Marschke, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
December 5, 1998
Endovascular treatment of life-threatening peripheral pulmonary artery stenosis
A B Fontaine, D E Wood, J J Borsa, et al.
Journal of Medicinal Chemistry
|
February 2, 1999
Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071)
L G Hamann, N S Mani, R L Davis, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g] quinolinone
J P Edwards, S J West, C L Pooley, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 1, 2000
Effects of isosteric pyridone replacements in androgen receptor antagonists based on 1,2-dihydro- and 1,2,3,4-tetrahydro-2,2-dimethyl-6-trifluoromethyl-8-pyridono[5,6-g]quin olines
J W Kong, L G Hamann, D A Ruppar, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 1, 2000
Nonsteroidal progesterone receptor antagonists based on 6-thiophenehydroquinolines
L Zhi, C M Tegley, B Pio, et al.
Journal of Medicinal Chemistry
|
February 17, 1998
5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists
L Zhi, C M Tegley, E A Kallel, et al.
Journal of the American College of Cardiology
|
December 1, 1996
Acute results of balloon angioplasty of native coarctation versus recurrent aortic obstruction are equivalent. Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators
B W McCrindle, T K Jones, W R Morrow, et al.
Journal of Medicinal Chemistry
|
August 28, 1998
Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore
C L Pooley, J P Edwards, M E Goldman, et al.
Gynecologic Oncology
|
October 1, 1982
Carcinoma of the uterine cervix FIGO Stage I-B
L L Adcock, T M Julian, T Okagaki, et al.
Page
of 8